News - Page 158 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board

MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board

Post published:August 10, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations

Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations

Post published:August 10, 2021
Post category:Press Release

Read more about the article MINDCURE Welcomes Dr. Ken Weingardt, Digital Therapy Visionary, as a Senior Clinical Technology Advisor to its Psychedelic Digital Therapeutics Team

MINDCURE Welcomes Dr. Ken Weingardt, Digital Therapy Visionary, as a Senior Clinical Technology Advisor to its Psychedelic Digital Therapeutics Team

Post published:August 10, 2021
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Post published:August 10, 2021
Post category:Press Release

Read more about the article Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe

Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe

Post published:August 9, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: UK Patent Examiner Questions Compass Patent; Canadians Overwhelmingly Support Psilocybin Policy Reform; No Data Protection for Spravato in Canada

Psychedelic Bulletin: UK Patent Examiner Questions Compass Patent; Canadians Overwhelmingly Support Psilocybin Policy Reform; No Data Protection for Spravato in Canada

Post published:August 6, 2021
Post category:Psychedelic Bulletin

Read more about the article Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

Post published:August 5, 2021
Post category:Press Release

Read more about the article PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

Post published:August 5, 2021
Post category:Press Release

Read more about the article Silo Wellness Brings Marley One Mushrooms to the U.K. Market through Distribution Agreement with LocoSoco Limited

Silo Wellness Brings Marley One Mushrooms to the U.K. Market through Distribution Agreement with LocoSoco Limited

Post published:August 5, 2021
Post category:Press Release

Read more about the article Psygen Announces Successful Closing of Oversubscribed Convertible Debenture Financing, Sets Value at $30mm

Psygen Announces Successful Closing of Oversubscribed Convertible Debenture Financing, Sets Value at $30mm

Post published:August 5, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.